The Food and Drug Administration's independent vaccine advisers voted in favor of authorizing Pfizer and BioNTech's Covid-19 vaccine for children ages 5-11.
Panel members voted 17-0 to recommend the shot, with one abstention.
Data presented by the Centers for Disease Control and Prevention at the panel's meeting Tuesday showed that children ages 5 to 11 are "at least as likely" as adults to contract Covid-19, and surveillance testing suggests pediatric cases are widely underreported. Hospitalization rates also are three times higher for children of color than for white kids, highlighting racial disparities also seen among adult patients.
An FDA staff analysis released late Friday suggested the product's benefits outweigh the risks of adverse side effects to kids. However, the document also noted that balance could change if Covid case rates again fell to those seen in June, depending on the extent to which instances of myocarditis — an inflammatory heart condition linked to messenger RNA vaccines — occur in that age group.
Fonte: POLITICO
Nenhum comentário:
Postar um comentário